Read More

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.

ATRA

Read More

BETS Announces Delivery Of The All Equipment At The Second Mining Farm; As Of Now, The Co Has Received An Initial Batch Of ~1,400 Miners, Mining Containers, Transformers, Sound Barriers And Other Equipment Required For The Operation

Bit Brother Limited (the "Company," "we", or "Bit Brother") (NASDAQ: BETS) is pleased to announce that all equipment for the operation of our second cryptocurrency mining farm have been delivered. Due to the

BETS